Merkzettel Warenkorb
  • Produktbild: Aging 2000: Our Health Care Destiny
  • Produktbild: Aging 2000: Our Health Care Destiny
  • Produktbild: Aging 2000: Our Health Care Destiny

Aging 2000: Our Health Care Destiny Volume 1: Biomedical Issues

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

26.09.2011

Herausgeber

Charles M. Gaitz + weitere

Verlag

Springer Us

Seitenzahl

546

Maße (L/B/H)

23,5/15,5/3,1 cm

Gewicht

861 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-1-4612-9544-0

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

26.09.2011

Herausgeber

Verlag

Springer Us

Seitenzahl

546

Maße (L/B/H)

23,5/15,5/3,1 cm

Gewicht

861 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-1-4612-9544-0

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Aging 2000: Our Health Care Destiny
  • Produktbild: Aging 2000: Our Health Care Destiny
  • Produktbild: Aging 2000: Our Health Care Destiny
  • for Volume I.- I. Overview.- 1. Health Care of the Aging: Trends, Dilemmas, and Prospects for the Year 2000.- 2. The Next Twenty Years: Medical Science and the Practice of Geriatrics.- II. Basic Mechanisms of Biologic Aging.- 3. The Biology of Aging and the Quality of Later Life.- 4. Extending the Mammalian Life Span.- 5. Aging Humans and Aging Cells.- 6. A Progress Report on Neurochemical and Neuroendocrine Regulation in Normal and Pathologic Aging.- 7. New Approaches to Alzheimer’s Disease: Neurotrophic Factors.- III. Neurochemistry of Aging and Age-Related Diseases.- 8. Neurochemistry of the Aging Brain and Senile Dementia.- 9. Brain Neurotransmitters in Normal Aging.- 10. Neuropeptides in Human Aging and Dementia.- 11. Receptor-Mediated Alterations of Central Monoaminergic Transmission in Aged Wistar Rats.- 12. Dopamine Receptors: Antiparkinsonian Activity and Molecular Mechanisms.- 13. Prolactin Studies in Senile Dementia of the Alzheimer Type.- 14. Prospects for Synergistic Drug Combinations for the Treatment of Senile Amnesias.- 15. Effects of Aging and Hypertension on Cerebral Blood Flow and Autoregulation in Normal Subjects and CVD Patients.- IV. Imaging Techniques.- 16. Imaging Techniques of the Aging Brain.- 17. Computerized Tomography (CT) and Positron Emission Tomography (PET) in Normal and Pathologic Aging.- V. Experimental Neuropathology.- 18. Cholinergic Deficiencies in Senile Dementia of the Alzheimer Type.- 19. Noncortical Transmitter-Specific Neurons in Senile Dementia of the Alzheimer Type.- 20. Neuropathology of the Aging Brain and Dementia of the Alzheimer Type.- VI. Prevention and Treatment of Physical Disorders.- 21. Interaction of Aging and Disease.- 22. Rational and Successful Health Care of Tomorrows Elderly: An Academic Perspective.- VII. Interface of Psychiatry and Medicine.- 23. Psychiatry versus Medicine: Am I My Brothers Keeper?.- 24. Toward an Interface of Mental and Physical Health Phenomena in Geriatrics: Clinical Findings and Questions.- VIII. Pharmacotherapy of Mental Illness in the Elderly.- 25. Pharmacotherapy of Mental Disorders of Old Age.- 26. Considerations for Treating the Elderly with Psychotropic Medications.- 27. Rationale for the Use of Therapeutic Agents in Affective Disorders (AD) and Senile Dementia of the Alzheimer Type (SDAT).- 28. Prospects for the Development of Safer Antipsychotic Agents for the Treatments of the Elderly.- 29. Prospects for Safer Pharmacologic Treatment of Affective Disorders in the Elderly.- IX. Dihydroergotoxine Mesylate (Hydergine).- 30. Hydergine: Interaction with Neurotransmitter Systems in the Central Nervous System.- 31. Implications of Long-Term Study of Hydergine in Elderly Patients with Chronic Senile Cerebral Insufficiency.- 32. Determinants of Successful Aging: Findings from a Study with Ergoloid Mesylates (Hydergine).- 33. Differential Patient Response to Ergoloid Mesylates According to Current Etiopathic Notions of Dementia.- 34. A Dose-Response Study of Dihydroergotoxine (DHET) Mesylate for Cerebrovascular Disturbances.- X. Psychiatric Treatment in the Future.- 35. The Mental Health Professional in a Preventive Role.- 36. Concepts of Depression in the Elderly: Signposts to Future Mental Health Needs.- 37. Psychiatric Treatments for the Aged: 2000 and Beyond.- 38. Aging and Mental Retardation: An International Perspective.- 39. Senile Dementia: Psychological and Behavioral Treatments.- 40. Implications of New Research for Care of Alzheimer’s Disease.- 41. The Future of Psychotherapy and the Elderly.- XI. A Look into the Future.- 42. “Old Wine in New Bottles”: Medical Care for the Elderly in the Year 2000.- 43. Health Care in the 21st Century: The Social and Ethical Context.- 44. Future Diagnostic and Therapeutic Strategies: A Realistic Forecast.- Epilogue.